Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 200,000,000
    Countries
    Sector(s)
    Germany : € 200,000,000
    Industry : € 200,000,000
    Signature date(s)
    30/06/2011 : € 200,000,000

    Summary sheet

    Release date
    14 June 2010
    Status
    Reference
    Signed | 30/06/2011
    20090708
    Project name
    Promoter - financial intermediary
    Evonik Chemicals RDI RSFF

    Evonik Industries AG

    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 200 million.
    EUR 660 million.
    Location
    Sector(s)
    Description
    Objectives

    Co-financing of the promoter’s research, development and innovation expenditure in the development of leading-edge technologies and strategic innovations in the field of specialty chemicals for different market applications.

    The project concerns investments in research and technology as well as product and process development driven by the promoter’s long-term strategy, focusing on high-value added products with the objective to strengthen the long-term competitive edge through technology and innovation leadership.

    Environmental aspects
    Procurement

    The R&D activities encompassed within this project will not materially change current R&D practices and will be carried out within existing facilities. Thus, an Environmental Impact Assessment (EIA) according to the EU Directive 97/11/EC, as amended by directive 2003/35/EC, should not be required. Compliance of R&D activities with relevant EU environmental legislation will be verified during appraisal.

    Procurement procedures followed and applicability of EU public procurement legislation will be verified during the appraisal.

    Comments

    The Risk Sharing Finance Facility (RSFF) is an innovative credit risk sharing scheme jointly set up by the European Commission and the European Investment Bank to improve access to debt financing for private companies or public institutions promoting activities with a higher financial risk profile in the fields of research, technological development, demonstration and innovation investments.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications